SCHEMBL22563552

SCHEMBL22563552

N#Cc1cc(-n2c3ccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)cc3c3cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)ccc32)c(-c2nc(-c3ccccc3)cc(-c3ccccc3)n2)cc1-n1c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2c2cc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.42
KMT2A Q03164 6/20 0.42
ALDH1A1 P00352 4/20 0.42
MAPT P10636 3/20 0.42
HPGD P15428 3/20 0.42
NTSR1 P30989 1/20 0.39
LMNA P02545 3/20 0.38
KDM4E B2RXH2 2/20 0.38
GLA P06280 1/20 0.38
SQOR Q9Y6N5 3/20 0.36
ABCG2 Q9UNQ0 1/20 0.36
CSNK2A1 P68400 1/20 0.36
ADORA2A P29274 2/20 0.35
ADORA1 P30542 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
MAPK1 P28482 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22563450 0.98 MEN1 (0.40) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21278787 0.95 MEN1 (0.42) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL19942790 0.95 CYP1A2 (0.37) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21278885 0.93 MEN1 (0.40) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL19942771 0.93 CYP1A2 (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL22563708 0.93 SQOR (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL19909347 0.92 MEN1 (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL23487306 0.92 MEN1 (0.43) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL19943175 0.92 CYP1A2 (0.36) MEN1KMT2AALDH1A1LMNAKDM4E
SCHEMBL22563468 0.91 SQOR (0.36) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210175434-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-10 US disclosed
EP-3580300-B1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-10-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210175434-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, OR51E2, OCIAD2 MEN1 2472/4885KMT2A 3474/4885ALDH1A1 80/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.